Xencor, Inc. (XNCR) is a publicly traded Healthcare sector company. As of September 2, 2026, XNCR trades at $26.93 with a market cap of $2.08B and a P/E ratio of -12.29. XNCR moved -3.60% today. Year to date, XNCR is +80.29%; over the trailing twelve months it is +222.93%. Its 52-week range spans $6.92 to $30.61. Analyst consensus is strong buy with an average price target of $30.29. Rallies surfaces XNCR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for XNCR, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $26.93 |
| Market Cap | $2.08B |
| P/E Ratio | -12.29 |
| EPS | $-2.17 |
| Dividend Yield | 0.00% |
| 52-Week High | $30.61 |
| 52-Week Low | $6.92 |
| Volume | 834.24K |
| Avg Volume | 0 |
| Revenue (TTM) | $104.97M |
| Net Income | $-163.32M |
| Gross Margin | 0.00% |
10 analysts cover XNCR: 0 strong buy, 9 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $30.29.